Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

WiSA Announces Certification of System Audio’s Legend Silverback Speakers

Published

on

Reading Time: 3 minutes

Legend 40 Silverback speaker wins “Best of HiFi Award” at HIGH END
2019 in Munich

SAN JOSE, Calif.–(BUSINESS WIRE)–WiSA®
LLC
, the Wireless Speaker and Audio Association founded by
Summit Wireless Technologies (NASDAQ: WISA) and comprised of leading
consumer electronics brands, today announces the certification of System
Audio
’s Legend Silverback speakers.

Available now through System Audio’s dealer network, this exciting new
line of digital speakers includes the SA Legend 60 Silverback floor
standing speaker (€8,199/pair), SA Legend 40 Silverback floor standing
speaker (€5,399/pair) and SA Legend 5 Silverback bookshelf speaker
(€3,000/pair).

The SA Legend Silverback present a unique family of active speakers that
can be used wirelessly with a WiSA hub or WiSA USB Transmitter or
connected to a preamplifier. Each speaker has 2-4 built-in digital
amplifiers of up to 560 watts, lossless digital active crossovers and a
digital signal processor (DSP). The speakers can be combined to create a
wireless 7.1 home theater system offering uncompressed audio in 24/96
high-definition resolution.

Recently showcased at the HIGH END 2019 trade show in Munich, the SA
Legend 40 Silverback floor standing speaker earned the “Best of Hifi
Award” from Germany’s HiFi Eins Null Magazine.

“WiSA’s technology is the most important innovation for high-end audio
in decades,” said Ole Witthoft, founder of System Audio. “It can be
difficult for listeners to integrate premium sound experiences into
their modern lifestyle and home decor, but WiSA and its interoperability
standard present the necessary solution. We are proud of our new WiSA
Certified™ Legend Silverback speakers and for playing a role in the
evolution and simplification of high-performance multichannel audio.”

All WiSA Certified and WiSA Ready™* components work together seamlessly
to deliver wireless, multi-channel audio and authentic movie theater
sound that immerses the listener into the middle of movies and video,
music, sports, gaming/esports and more. As a result, consumers can
expect an audiophile experience, but unlike traditional audio systems,
set up is simple and takes just minutes even for larger 5.1 and 7.1
setups.

“It’s exciting to be adding new members and certifying audio systems at
such a great pace in 2019,” said Tony Ostrom, president of WiSA. “System
Audio is a staple in the industry, and the Legend Silverback speakers
are stunning examples of what is possible when great brands implement
powerful technology.”

The WiSA Association and its members are committed to revolutionizing
the home entertainment experience by delivering immersive, uncompressed,
high-definition, multichannel sound through the universal standards
established and certified by the WiSA Association.

For more information about the WiSA Association, its technology and
products, please visit www.wisaassociation.org.

About System Audio

Established in Denmark in 1984, System Audio is an award-winning
loudspeaker manufacturer whose speakers are known for their simple
Scandinavian design, superb build quality and extraordinary sound.
System Audio values tradition, craftsmanship and modern innovative
technologies and is committed to bringing music and movie lovers closer
to the artists and away from technological complexity. For more
information about System Audio, please visit: www.system-audio.com.

About WiSA, LLC

WiSA, the (Wireless Speaker and Audio) Association is a consumer
electronics consortium dedicated to creating interoperability standards
utilized by leading brands and manufacturers to deliver immersive sound
via intelligent devices. WiSA Certified components from any member brand
can be combined to dramatically increase the enjoyment of movies and
video, music, sports, gaming/esports, and more. WiSA also ensures
robust, high definition, multi-channel, low latency audio while
eliminating the complicated set-up of traditional audio systems. For
more information about WiSA, please visit: www.wisaassociation.org.

About Summit Wireless Technologies, Inc.

Summit Wireless Technologies, Inc. (NASDAQ: WISA) is a leading provider
of immersive, wireless sound technology for intelligent devices and next
generation home entertainment systems. Working with leading CE brands
and manufacturers such as Harman International, a division of Samsung,
LG Electronics, Klipsch, Bang & Olufsen, Xbox, a subsidiary of
Microsoft, and others, Summit Wireless delivers seamless, dynamic audio
experiences for high-definition content, including movies and video,
music, sports, gaming/esports, and more. Summit Wireless is a founding
member of WiSA, the Wireless Speaker and Audio Association and works in
joint partnership to champion the most reliable interoperability
standards across the audio industry. Summit Wireless, formerly named
Summit Semiconductor, Inc., is headquartered in San Jose, CA with sales
teams in Taiwan, China, Japan, and Korea. For more information, please
visit: www.summitwireless.com.

* WiSA Ready TVs, gaming PCs and console systems are “ready” to transmit
audio to WiSA Certified speakers when a WiSA USB Transmitter is plugged
in and a user interface is activated through an APP or product design
like LG TVs.

© 2019 Summit Wireless Technologies, Inc. All rights reserved. Summit
Wireless Technologies and the Summit Wireless logo are trademarks of
Summit Wireless Technologies, Inc. The WiSA logo, WiSA, WiSA Ready, and
WiSA Certified are trademarks, or certification marks of WiSA LLC.
Third-party trade names, trademarks and product names are the
intellectual property of their respective owners.

Contacts

Ashley Eggert
Dittoe PR for WiSA
317-202-2280
[email protected]

Mary Magnani or Kirsten Chapman
LHA Investor Relations for Summit
Wireless Technologies
415.433.3777
[email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland

Published

on

Continue Reading

Cannabis

Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa

Published

on

Continue Reading

Innocan

Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey

Published

on

innocan-pharma-reports-breakthrough-in-a-pre-clinical-trial:-liposomal-cbd-injection-restores-mobility-to-an-amputee-female-donkey

HERZLIYA, Israel and ALGARY, AB, May 9, 2024 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce the successful pre-clinical treatment with a liposomal-CBD injection in a female donkey. Innocan’s innovative therapy provided immediate noticeable pain relief and improved mobility.

Miri, a 7-year-old female donkey, underwent amputation of her right front limb at a young age, resulting in a weight burden primarily borne by her left front limb. Consequently, she developed laminitis in her left front limb, an inflammatory disease affecting the soft tissue that connects the foot bone to the hoof, seemingly causing extreme pain and limited mobility. Over time, Miri’s condition worsened, culminating in the formation of a abscess in the affected hoof, which appeared to have intensified her pain. Despite receiving pain relief medications, Miri found no respite, was unable to move, and her caregivers were advised to euthanize her.

As an act of compassionate therapy, the female donkey was administered a liposomal-CBD injection. The effect was immediate, with Miri becoming active and roaming the farm. Following the liposomal-CBD injection, the abscess in her affected foot healed, and Miri regained her ability to walk and move as she did before her laminitis developed.

“Thanks to our innovative liposomal-CBD injection, we are thrilled to have brought relief to Miri, eliminating the need for euthanasia,” commented Iris Bincovich, CEO of Innocan. “Once again, Innocan has shown liposomal-CBD to be effectively active for pain relief and well-being. We see this pre-clinical treatment as strong evidence of liposomal-CBD’s potential to improve the lives of animal patients and potentially human patients.”

“Laminitis is a crippling condition well familiar and common in horses,” said Prof Chezy Barenholz, the Chief Scientific Officer of Innocan. “The disease results in severe pain condition, representing another big market for liposomal-CBD with great potential to treat horses. Innocan is dedicated to advancing the development of CBD-based therapeutics for various indications in both humans and animals.”

For further information and a supporting video, please see: https://youtu.be/Hgqh2WOlwJQ?si=oGgSYrGi3rkW-RC

About Innocan Pharma:

Innocan is a pharmaceutical tech company that operates under two main segments: Pharmaceuticals and Consumer Wellness. In the Pharmaceuticals segment, Innocan focuses on developing innovative drug delivery platform technologies comprises with cannabinoids science, to treat various conditions to improve patients’ quality of life. This segment involves two drug delivery technologies: (i) LPT CBD-loaded liposome platform facilitating exact dosing and the prolonged and controlled release of CBD into the blood stream. The LPT delivery platform research is in the preclinical trial phase for two indications: Epilepsy and Pain Management. In the Consumer Wellness segment, Innocan develops and markets a wide portfolio of innovative and high-performance self-care products to promote a healthier lifestyle. Under this segment Innocan has established a Joint Venture by the name of BI Sky Global Ltd. that focuses developing on advanced targeted online sales. https://innocanpharma.com/

Contact Information:

For Innocan Pharma Corporation:

Iris Bincovich, CEO

+1 5162104025

+972-54-3012842

+442037699377

[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution Regarding Forward-Looking Information

Certain information set forth in this news release, including, without limitation, the Company’s plans for human trials of its LPT-CBD platform, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. . The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of production and distribution arrangements.

Forward-looking information is subject to various risks and uncertainties that could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: global and local (national) economic, political, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and potential disruption of relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import/export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner). The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release. A comprehensive discussion of other risks that impact Innocan can be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedarplus.ca.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

Logo: https://mma.prnewswire.com/media/2046271/3968398/Innocan_Pharma_Corporation_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/innocan-pharma-reports-breakthrough-in-a-pre-clinical-trial-liposomal-cbd-injection-restores-mobility-to-an-amputee-female-donkey-302141590.html

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania